FTXH Fees and Costs — First Trust Nasdaq Pharmaceuticals ETF
Data updated: 2026-08-21
The net expense ratio is 0.60%. There are no sales loads or redemption fees. In fiscal 2026 the fund paid $3K in broker commissions, 0.0140% of average net assets, and portfolio turnover was 35%.
FTXH Fees and Expenses
Annual operating expenses and sales charges of FTXH. Prospectus, as of March 31, 2026.
| Annual operating expenses | |
|---|---|
| Management fee | 0.60% |
| 12b-1 fee | 0.00% |
| Other expenses | 0.00% |
| Gross expense ratio | 0.60% |
| Fee waiver | — |
| Net expense ratio | 0.60% |
| Sales charges | |
|---|---|
| Max front load | 0.00% |
| Max deferred load | — |
| Redemption fee | — |
| Expense limitation in place (N-CEN) | No |
| Fees waived or reduced during the year | No |
| Waived fees subject to recoupment | No |
FTXH Costs Over Time
On $10,000 invested in FTXH, assuming 5% a year before costs, total costs come to $387 over 5 years, cutting the return by 0.64% a year. Illustration, not a forecast: it assumes today's net expense ratio throughout (a fee waiver may end).
| $10,000 invested | Sell after 1 year | Sell after 3 years | Sell after 5 years |
|---|---|---|---|
| Value before costs | $10,500 | $11,576 | $12,763 |
| Fund expenses (net expense ratio 0.60%) | $63 | $197 | $344 |
| Trading costs (broker commissions) | $1 | $5 | $8 |
| Lost growth on money paid in costs | $0 | $10 | $35 |
| Total costs | $64 | $212 | $387 |
| Value after costs | $10,436 | $11,364 | $12,376 |
| Impact on return, per year | 0.64% | 0.64% | 0.64% |
FTXH Trading Costs
Brokerage costs reported on SEC Form N-CEN for the fiscal year ending March 31, 2026.
- Explicit cost rate (commissions ÷ average net assets): 0.0140%
- Total broker commissions: $3K
- Bought from dealers (principal trades, not a cost): $22.6M
- Portfolio turnover (prospectus): 35%
- Securities lending: none during the year
FTXH Agency Brokers
Commissions paid.
| Broker | Amount | Share |
|---|---|---|
| CANTOR FITZGERALD & CO. | $1K | 54.57% |
| OLD MISSION MARKETS LLC | $1K | 43.35% |
| MIZUHO SECURITIES USA LLC | $32 | 1.18% |
| CITADEL SECURITIES LLC | $15 | 0.54% |
| BOFA SECURITIES, INC. | $10 | 0.36% |
FTXH Dealer Counterparties
Securities bought directly from dealers (principal trades).
| Broker | Amount | Share |
|---|---|---|
| BOFA SECURITIES, INC. | $6.4M | 28.40% |
| MORGAN STANLEY & CO. LLC | $6.1M | 27.11% |
| CITADEL SECURITIES LLC | $3.5M | 15.39% |
| VIRTU AMERICAS LLC | $3.2M | 14.28% |
| Jane Street Execution Services, LLC | $1.7M | 7.45% |
| GOLDMAN SACHS & CO. LLC | $1.7M | 7.37% |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.